Clinical Trial Update: Study on Intravenous Injection of SHR-1906 in the Treatment of Idiopathic Pulmonary Fibrosis [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating intravenous SHR-1906 for idiopathic pulmonary fibrosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Pulmonary Fibrosis

Drugs mentioned

• SHR-1906

Snippet

Sponsor: Guangdong Hengrui Pharmaceutical Co., Ltd | Conditions: Idiopathic Pulmonary Fibrosis | Phase 2 | Status: COMPLETED